Cargando…

Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases

The main objectives of this review are to survey the current literature on the role of epigenetics in determining the fate of stem cells and to assess how this information can be used to enhance the treatment strategies for some neurodegenerative disorders, like Huntington’s disease, Parkinson’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinageshwar, Bhairavi, Maiti, Panchanan, Dunbar, Gary L., Rossignol, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783933/ https://www.ncbi.nlm.nih.gov/pubmed/26848657 http://dx.doi.org/10.3390/ijms17020199

Ejemplares similares

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Current Therapeutic Strategies for Glioblastoma
por: Rossignol, Julien, et al.
Publicado: (2019)

Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases
por: Maiti, Panchanan, et al.
Publicado: (2018)

Inducible Knockout of 14-3-3β Attenuates Proliferation and Spheroid Formation in a Human Glioblastoma Cell Line U87MG
por: Gallo, Kellie, et al.
Publicado: (2023)

PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
por: Fana, Michael, et al.
Publicado: (2020)

Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington’s Disease
por: Gharaibeh, Abeer, et al.
Publicado: (2020)

Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease
por: Al-Gharaibeh, Abeer, et al.
Publicado: (2017)

Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
por: Wyse, Robert D., et al.
Publicado: (2014)

Use of Polyamidoamine Dendrimers in Brain Diseases
por: Florendo, Maria, et al.
Publicado: (2018)

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease
por: Kolli, Nivya, et al.
Publicado: (2017)

Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease
por: Dunbar, Gary L., et al.
Publicado: (2019)

Transplantation of mesenchymal stem cells overexpressing interleukin‐10 induces autophagy response and promotes neuroprotection in a rat model of TBI
por: Maiti, Panchanan, et al.
Publicado: (2019)

Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits, Gliosis, and Amyloid-Beta Deposition in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Bowers, Zackary, et al.
Publicado: (2021)

Correction: Bowers et al. Tart Cherry Extract and Omega Fatty Acids Reduce Behavioral Deficits and Gliosis in the 5xFAD Mouse Model of Alzheimer’s Disease. Brain Sci. 2021, 11, 1423
por: Bowers, Zackary, et al.
Publicado: (2023)

Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42
por: Maiti, Panchanan, et al.
Publicado: (2017)

Molecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin
por: Maiti, Panchanan, et al.
Publicado: (2014)

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
por: Maiti, Panchanan, et al.
Publicado: (2017)

Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease
por: Manna, Jayeeta, et al.
Publicado: (2021)

Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
por: Maiti, Panchanan, et al.
Publicado: (2018)

Retraction Note: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
por: Maiti, Panchanan, et al.
Publicado: (2023)

Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
por: Paladugu, Leela, et al.
Publicado: (2021)

A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers
por: Munro, Nikolas, et al.
Publicado: (2019)

A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments
por: Maiti, Panchanan, et al.
Publicado: (2019)

Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines
por: Gallien, John, et al.
Publicado: (2021)

Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin
por: Maiti, Panchanan, et al.
Publicado: (2017)

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014)

Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells
por: Maiti, Panchanan, et al.
Publicado: (2019)

Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
por: Maiti, Panchanan, et al.
Publicado: (2021)

Correction to: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
por: Maiti, Panchanan, et al.
Publicado: (2022)

Retraction Note: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis
por: Maiti, Panchanan, et al.
Publicado: (2023)

TDP-43 Epigenetic Facets and Their Neurodegenerative Implications
por: Gimenez, Juliette, et al.
Publicado: (2023)

PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
por: Srinageshwar, Bhairavi, et al.
Publicado: (2017)

Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease
por: Maiti, Panchanan, et al.
Publicado: (2020)

The emerging epigenetics of PARK7 and its implication in neurodegenerative disease
por: Vavougios, George D., et al.
Publicado: (2018)

Tetrahydrocurcumin Has Similar Anti-Amyloid Properties as Curcumin: In Vitro Comparative Structure-Activity Studies
por: Maiti, Panchanan, et al.
Publicado: (2021)

Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective
por: Xu, Sutong, et al.
Publicado: (2021)

Epigenetic Changes in Neurodegenerative Diseases
por: Kwon, Min Jee, et al.
Publicado: (2016)

Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2023)

The potential of epigenetic therapies in neurodegenerative diseases
por: Coppedè, Fabio
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l7lu6q1ug83ag2j01hrrqho892